HomeZA71 • FRA
add
Larimar Therapeutics Inc
Previous close
€2.56
Day range
€2.32 - €2.32
Year range
€1.50 - €9.60
Market cap
140.86M USD
Avg Volume
83.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.19M | 86.38% |
Net income | -29.28M | -99.82% |
Net profit margin | — | — |
Earnings per share | -0.46 | -70.37% |
EBITDA | -31.10M | -86.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 157.53M | -30.70% |
Total assets | 170.18M | -31.44% |
Total liabilities | 25.90M | 49.21% |
Total equity | 144.27M | — |
Shares outstanding | 64.03M | — |
Price to book | 1.14 | — |
Return on assets | -42.10% | — |
Return on capital | -47.82% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -29.28M | -99.82% |
Cash from operations | -26.54M | -154.92% |
Cash from investing | 14.45M | 121.13% |
Cash from financing | — | — |
Net change in cash | -12.09M | -114.50% |
Free cash flow | -15.99M | -208.87% |
About
Founded
2005
Headquarters
Website
Employees
65
